Keyword: Novo Nordisk

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...

News

Novozymes and Novo Nordisk Partner on Enzymes

30.11.2021 -

Danish companies Novozymes and Novo Nordisk Pharmatech are teaming up to develop technical enzymes to support biopharma processing. The companies aim to develop high...

News

Novo Nordisk Buys Dicerna Pharmaceuticals

22.11.2021 -

Danish pharma Novo Nordisk has agreed to buy Dicerna Pharmaceuticals, offering $3.3 billion for the US biopharma and its ribonucleic acid interference (RNAi) platform.

News

Novo Nordisk Takes Prothena’s ATTR Amyloidosis Program

20.07.2021 -

Danish drugmaker Novo Nordisk has acquired Prothena’s clinical-stage stage antibody PRX004 and broader ATTR amyloidosis program, gaining full global rights to the...

News

Novo Nordisk to Buy Emisphere Technologies

09.11.2020 -

Danish drugmaker Novo Nordisk has agreed to buy US drug delivery company Emisphere Technologies for $1.8 billion.

News

Evotec Enters Multiple Drug Discovery Pacts

26.08.2020 -

German drug discovery and development company Evotec has struck four separate partnership agreements during August.

News

Novo Nordisk Buys Cardio-renal Group Corvidia

15.06.2020 - Danish drugmaker Novo Nordisk has agreed to buy Corvidia Therapeutics, a privately held, US-based clinical-stage company focused on the research and development of transformative...

News

Novo Nordisk to Upgrade Danish Insulin Plant

12.02.2020 - Novo Nordisk has announced it will spend 800 million Danish Kroner (DKK, about $117.4 million) to further upgrade its insulin production site at Kalundborg, Denmark. The site’s...